Another study showed that overexpression of CASC2 can reduce the ability of HCC invasion and metastasis, and promote apoptosis by inactivating the protein kinase signaling pathway, thereby reducing the metastasis ability of HCC cells [111]. This evidence concerns the gene CASC2 and hepatocellular carcinoma.